PL2337567T3 - Preparat weterynaryjny - Google Patents

Preparat weterynaryjny

Info

Publication number
PL2337567T3
PL2337567T3 PL09788414T PL09788414T PL2337567T3 PL 2337567 T3 PL2337567 T3 PL 2337567T3 PL 09788414 T PL09788414 T PL 09788414T PL 09788414 T PL09788414 T PL 09788414T PL 2337567 T3 PL2337567 T3 PL 2337567T3
Authority
PL
Poland
Prior art keywords
veterinary preparation
veterinary
preparation
Prior art date
Application number
PL09788414T
Other languages
English (en)
Inventor
Andrzej Krzysztof Siwicki
Jan Gluszak
Original Assignee
Przed Wielobranzowe Vet Agro Sp Z O O
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Przed Wielobranzowe Vet Agro Sp Z O O filed Critical Przed Wielobranzowe Vet Agro Sp Z O O
Publication of PL2337567T3 publication Critical patent/PL2337567T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/133—Amines having hydroxy groups, e.g. sphingosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A61K31/708—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid having oxo groups directly attached to the purine ring system, e.g. guanosine, guanylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Zoology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL09788414T 2008-08-12 2009-08-05 Preparat weterynaryjny PL2337567T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PL385868A PL223158B1 (pl) 2008-08-12 2008-08-12 Zastosowanie metyzoprynolu
EP09788414.2A EP2337567B1 (en) 2008-08-12 2009-08-05 Veterinary preparation
PCT/PL2009/000079 WO2010019059A1 (en) 2008-08-12 2009-08-05 Veterinary preparation

Publications (1)

Publication Number Publication Date
PL2337567T3 true PL2337567T3 (pl) 2015-06-30

Family

ID=41202792

Family Applications (2)

Application Number Title Priority Date Filing Date
PL385868A PL223158B1 (pl) 2008-08-12 2008-08-12 Zastosowanie metyzoprynolu
PL09788414T PL2337567T3 (pl) 2008-08-12 2009-08-05 Preparat weterynaryjny

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL385868A PL223158B1 (pl) 2008-08-12 2008-08-12 Zastosowanie metyzoprynolu

Country Status (3)

Country Link
EP (1) EP2337567B1 (pl)
PL (2) PL223158B1 (pl)
WO (1) WO2010019059A1 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107158023A (zh) * 2017-04-12 2017-09-15 陈小瑞 防治草鱼和青鱼的病毒性出血病的药物组合物及制备方法
PL425725A1 (pl) * 2018-05-24 2019-12-02 Przed Wielobranzowe Vet Agro Spolka Z Ograniczona Odpowiedzialnoscia Produkt leczniczy zawierający wodny roztwór metyzoprynolu o ulepszonej trwałości
WO2022123510A1 (en) * 2020-12-10 2022-06-16 Reena Patel Methisoprinol compositions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1270832B (it) 1993-09-20 1997-05-13 Luciano Brugola Composizione farmaceutica antivirale contenente la 2-ammino 4,6 dicloropirimidina e metisoprinolo.
WO2003013544A1 (es) * 2001-08-08 2003-02-20 Laboratorios Químicos Industriales, S.A. Medicamento antiviral para utilizarse en el control de la enfermedad mancha blanca en camarones
PL194749B1 (pl) 2001-08-30 2007-06-29 Przed Wielobranzowe Vet Agro S Preparat żelazowy

Also Published As

Publication number Publication date
PL223158B1 (pl) 2016-10-31
EP2337567B1 (en) 2014-12-31
EP2337567A1 (en) 2011-06-29
PL385868A1 (pl) 2010-02-15
WO2010019059A1 (en) 2010-02-18

Similar Documents

Publication Publication Date Title
ZA201006679B (en) Orally-disintergrating solid preparation
GB0815435D0 (en) Formulations
IL211233A0 (en) Vaccine
GB2459691B (en) Formulations
GB0823269D0 (en) Formulations
IL208651A0 (en) Vaccine
GB0821789D0 (en) Formulations
GB0810710D0 (en) Vaccine
ZA201007402B (en) Vaccine
EP2307021A4 (en) FORMULATIONS
GB0822633D0 (en) Formulation
GB0816447D0 (en) Vaccine
GB0816284D0 (en) Vaccine
ZA201004772B (en) Novel formulation
GB0814376D0 (en) Formulation
PL2319515T3 (pl) Kombinacja przeciwko kokcydiom do zastosowania weterynaryjnego
GB0921378D0 (en) Formulations
GB0916030D0 (en) Formulations
GB0822171D0 (en) Temisartan formulations
GB0811019D0 (en) Odontalgic preparation
GB0807906D0 (en) Formulations
GB0916106D0 (en) Formulations
GB0817079D0 (en) Formulations
GB0816876D0 (en) Formulations
GB0823493D0 (en) Formulations